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Background: Conventional cohort studies have consistently shown that exposure to maternal smoking in pregnancy is associated with about twice the risk of attention deficit hyperactivity disorder (ADHD) in the offspring. However, recent studies using alternative designs to disentangle the effect of social and genetic confounders have suggested that confounding may account for the association. In this study we aimed to estimate the association by a sibling design.
Methods: We used a design with half and full siblings in a Danish national register-based cohort on all singletons born between January 1991 and December 2006 and followed until January 2011. Data were available for 90% (N=968,665) of the singleton live births in the period. We used the combination of the International Classification of Diseases (10th version) diagnosis of hyperkinetic disorder (HKD) and ADHD medication to identify children. We used sibling-matched (conditional) Cox regression to control social and genetic confounding.
RESULTS: Using conventional cohort analyses, we found the expected association between pregnancy smoking and offspring ADHD (adjusted HR 2.01, 95% CI 1.94-2.07). In the sibling analysis, however, we did not detect such a strong association (adjusted HR 1.07, 95% CI 0.94-1.22). There was no difference between results for half- and full sibling analyses. The link between pregnancy smoking and low birth weight remained robust in the sibling design (adjusted OR 1.68, 95% CI 1.33-2.12).
CONCLUSIONS: We found no support for prenatal smoking as a strong causal factor in ADHD. Our findings suggest that the strong association found in most previous epidemiological studies is likely to be due to a strong link between maternal smoking and maternal ADHD genetics or shared family environment. Pregnant women should still be encouraged to stop smoking because of other risks, but we have no reason to believe that this would reduce the risk of ADHD in the offspring.
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It is widely accepted that exposure to maternal smoking in pregnancy may have a causal role in the etiology of attention deficit hyperactivity disorder (ADHD) ADDIN EN.CITE (; ; ; ), because of the consistency of the associations across studies. Further, the associations remain after controlling for possible confounding factors and animal studies  ADDIN EN.CITE () show that prenatal exposure to nicotine may influence brain development. On the other hand, animal models have consistently shown an effect in reducing birth weight, but they have not consistently demonstrated the motor and cognitive changes associated with ADHD  ADDIN EN.CITE (). Moreover, conventional statistical adjustments may to a certain extent control for known and measured confounders, but they cannot control for those that are unmeasured and unknown unless they correlate with factors that are controlled (). Studies that used the different types of natural experiment to control for the possibility of genetic mediation have all questioned the causal inference with respect to ADHD. This applies to the contrast within Assisted Reproductive Technologies of those that do and those that do not maintain genetic links between mother and child  ADDIN EN.CITE (), the contrast between maternal and paternal smoking effects  ADDIN EN.CITE (), and sibling studies  ADDIN EN.CITE (; ; ; ).

There is a need for studies with better confounders control and sibling studies, especially with identification of full and half-siblings which we provide here, to control potential social and genetic confounding. Full siblings share 50% of their genes, whereas e.g. maternal half-sibling share only 25% all from their mother. It follows that control for genetic mediation will be less in the latter case but that the fetal environment and contribution by maternal genes will be similar.





Denmark maintains a mandatory registration of all births in the Medical Birth Register (). By using the unique personal identification number assigned to all residents in Denmark, we linked all live births born from 1991 to 2006 with data from the Hospital Discharge Register () including all inpatient (established in 1977) and all outpatient visits (established in 1995). Registration is mandatory for all inpatient care in public and private hospitals as well as for all outpatient visits in public hospitals. All diagnoses were reported using the International Classification of Diseases, 10th version (ICD-10) (). We also used information on ADHD medication from the Register of Medicinal Product Statistics (). Parents and children are linked in the Civil Registration System (). The Danish data protection agency approved the study (J.nr. 2008-41-2663).

Cohort definition
We identified a total of 1,074,111 singletons born between January 1, 1991 and December 31, 2006 from the Medical Birth Register (). We excluded 1673 children who died before January 1, 2011. We further excluded 103,773 (11%) with missing smoking information, leaving 968,665 available for analysis. Of these, 12,812 children fulfilled ICD-10 diagnostic criteria, 7573 received ADHD medication without being registered with an ADHD diagnosis, and out of these 4569 had received ADHD medication for at least half a year. There were 20,385 children who either fulfilled ICD-10 diagnostic criteria or received ADHD medication. Restricting to those who received ADHD medication for at least half a year we end up with 17,381 children. A total of 587,130 participating women contributed with an average of 1.8 children to the entire cohort, with 223,587 having one, 269,681 having two, and 93,862 having three or more singletons.

Exposure information
Antenatal care in Denmark is free-of-charge (tax-paid) and offered to all pregnant women. The care in low risk pregnancy includes approximately 10 antenatal visits to their general practitioner and midwife. The data on maternal smoking were provided by the pregnant women to their general practitioner and registered by the midwives at birth and subsequently archived in the Medical Birth Register. During the period from 1991 to 1995, women were categorised as non-smokers or smokers. From 1996 onwards the smoking information included average number of cigarettes and whether the pregnant woman stopped smoking during the first trimester of pregnancy.

Outcome definition
We identified children with ADHD using a combination of the ICD-10 diagnosis for HKD (hyperkinetic disorder) and prescription of ADHD medicine The ICD-10 system is in Denmark used as registration system by hospitals. However, children are generally diagnosed based on DSM criteria. As the ICD definition is more narrow and because children are also diagnosed by specialists working outside the hospital this combination provides the best possible way to identify children with ADHD in Denmark We included the children's entries in the Hospital Discharge Register until January 1, 2011, using ICD-10 diagnoses to identify children with HKD including hyperkinetic disorder (F90.0), hyperkinetic conduct disorder (F90.1), or other hyperkinetic disorder (F90.8 and F90.9).

Information on ADHD medication was obtained from the Register of Medicinal Product Statistics until January 1, 2012 (). All Danish residents get subsided medicine for most physician-prescribed drugs, including ADHD medication: N06BA04 (central stimulating drug only methylphnidate), N06BA09 (Noradrenalin reuptake inhibitors, Atomoxetin), and N06BA07 (Modafinil). The first ADHD medication is defined when a child received any of the above medications after three years of age.

We a priori decided to focus on the definition of ADHD including children with the ICD-10 diagnosis or prescription of ADHD medication for at least half a year. We further performed the analyses using the following two alternative definitions 1) children with the ICD-10 diagnosis or 2) the ICD-10 diagnosis or ADHD medication. We expected association to be highest for the hospitalized cases since false positives are less likely for this group.

Statistical analyses
To control for differences in length of follow up time we used the Cox regression analysis, with child age as the primary time scale. The follow-up started when the child was three years of age and ended at the date of receiving a HKD diagnosis or an ADHD medication, emigration, or the end of follow-up (January 1, 2011), whichever came first. To control for the increasing incidence of ADHD over study time, we adjusted for each year of birth as a categorical variable (1991-2006). Because the comparison of cohort and sibling analyses was the aim of this study we a priori decided to adjust for child sex, maternal age and parity. The finding that boys and children born to younger mothers more often get the ADHD diagnosis is consequently found in the ADHD literature and clinical setting. Hazard Ratios (HR) are presented with 95% confidence intervals (CI). Our analytic strategy was to analyze the study population using regular cohort analyses and then to compare these results with sibling-matched analyses. Sibling-matched analyses provide internal comparison within families and assume that past smoking plays no etiologic role. The analyses were performed in STATA 11.1.

Population cohort analyses
Because most women contributed to the cohort with more than one child, we used robust standard errors by using the Huber-White sandwich estimator for correction of standard errors in the analyses involving siblings - declaring each of the sibling pairs to be a cluster to adjust the confidence intervals.

Sibling-matched analyses
We performed sibling-matched analyses to control for shared genetic and social confounding. We used stratified Cox regression with a separate stratum for each family identified by the mothers and fathers encrypted identification number. Full siblings were defined as children with same mother and father and maternal half-siblings were defined as children with the same mother but with different fathers.

In the stratified Cox regression model, each family has its own baseline rate function reflecting the family’s shared genetic and social factors. The exposure comparisons, smoking versus non-smoking, are thus made within the family. We controlled for the same factors as in the cohort analyses. The stratified Cox regression model is an extension of the paired binomial model, taking into account the differences in follow-up time. Thus only sibling pairs discordant for smoking as well as ADHD were ‘informative’, i.e. contributed information to the estimates. Indeed, to be informative, the sibling without ADHD should have at least as long a follow-up time as the sibling with ADHD.

To evaluate the sibling design, we used low birth weight to see if the model would identify the well-established effect of smoking on low birth weight  ADDIN EN.CITE (; ).

Results
The cohort characteristics are shown in Table 1. A total of 17,381 children had either an ICD-10 diagnosis of HKD and/or a prescription of ADHD medication for at least half a year. The median follow-up time was 9 years (range: 0-17 years). In Table 2 we compared results of the conventional cohort design with different sibling sex combinations using the full cohort with dichotomized smoking information. In the full cohort we found that children exposed to maternal smoking in pregnancy had about twice the risk of ADHD, whereas the sibling analyses showed no significant association between smoking and ADHD. Overall we found quite similar results for all sex combinations. There was no difference between the results of the half- and full sibling analyses.

Using the younger part of the cohort born from 1996 to 2006 where detailed smoking information was available, we found a dose response association in the conventional cohort analyses but no association in the sibling analyses (Table 3). There was no significant difference between the half- and full sibling analyses.

Testing the association between smoking and low birth weight (Table 4), we found a reduction but still a strong association with an adjusted OR of 1.68 (95% CI 1.33-2.12) in the sibling analyses.

We finally repeated the ADHD analyses using the two alternative definitions of ADHD, and the results were similar to those presented (results available upon request).

Discussion
Using the entire Danish birth population from a 15-year period, we found that in the cohort analysis, children prenatally exposed to maternal smoking had twice the risk of ADHD in children of non-smokers. This finding is in line with previous studies. When making internal comparison within families much of this association disappeared. These findings are in line with recent studies that used similar methods that used both ICD diagnoses and medication as indicator of ADHD (), or only one of them as indicator of ADHD  ADDIN EN.CITE (; ; ). We have recently reported that there is a stronger correlation of maternal than paternal (albeit present) smoking with offspring ADHD diagnosis as well as behaviour, indicating genetic confounding may be present  ADDIN EN.CITE (). We have also shown that women using nicotine replacement had nearly the same risk as smokers. The most likely explanation of the finding of these studies is the strong linkage between nicotine dependency and ADHD in these women, as smoking may be used in self-treatment of ADHD. We find similar results when comparing maternal half- and full siblings suggesting that maternal genetic or shared family environmental confounding can explain the consistent statistical association found in unmatched cohort analyses. We did unfortunately not have the smoking information of the fathers or could perform the analyses of paternal half-siblings.

Our study corroborated an effect of prenatal smoking exposure in reducing birth weight, in line with experimental animal models. Our study advances knowledge, however, in three major respects. First, it is based on a national, complete population-based cohort using established diagnostic criteria of clinical examinations from specialised departments within the public health services as well as medication records. We had almost complete follow-up data with little risk of selection bias, and our data came from concurrently registered information rather than retrospective reports. It is possible that our sibling results are biased by differential misclassification of ADHD. Although children’s care is universally available, publicly financed and organised in Denmark, we know that diagnosing ADHD is not perfect and a family occurrence may increase the diagnostic sensitivity. It is, however, unlikely that the threshold for admission to hospital clinics is related to the prenatal smoking, especially when siblings are compared.

We had similar findings for full siblings and half siblings suggesting that the statistical association between maternal smoking and ADHD is predominantly linked to maternal genetics or family environment. We included birth weight as a proof of sibling comparison models for testing the prenatal smoking effect on a well-established outcome, because animal models, as well as human studies, have all shown an effect of smoking exposure  ADDIN EN.CITE (; ). Thus, our confirmation within the matched sibling design provided well support of the method.

There are limitations to the sibling design that should be mentioned. The strict control for shared family factors limits the analyses to a quite small subset of the population, namely those women who managed to change smoking habits from one pregnancy to another and further had a strong genetic component for ADHD in the family. Despite the obvious limitation in extrapolation to all smokers, it may however from a public health point of view be the most interesting group to focus on.

By using a HKD diagnosis as well as ADHD medication to define ADHD cases, we believe that we identified the majority of the most severe phenotypes. A HKD diagnosis requires hyperactivity and impulsivity as well as inattention in at least two settings and is close to the DSM-IV ADHD-combined diagnosis. Although the Danish Hospital Discharge Register contains complete information for inpatient as well as outpatient contacts in the public health system, we have a parallel also tax financed system of psychiatrists working outside the hospital system, who are not obliged to register diagnoses centrally. As a consequence some children may remain unrecognized in the registers of diagnosis and thus diagnosed and treated without contact to the hospital system. We could identify those who received ADHD medication, but had no chance to identify non-medicated children diagnosed outside the hospital system.

Differences in referral, which in conventional cohort studies may lead to bias, are less likely to do so in a sibling design, because this bias is likely to be linked to the families. However, it is possible that a diagnosis given to a child will make it more likely that an undiagnosed sibling with the disorder will be diagnosed. Further, ADHD is not well defined and far from all with the disease are diagnosed. A case in the family will also probably lower the threshold for diagnosing another. In the sibling design this would generate fewer discordant pairs, but it would attenuate the estimate.
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	It is well known that maternal smoking during pregnancy is associated with a higher risk of ADHD in offspring.
	In this nation-wide register based study half and full sibling analyses did not reveal any causal role of pregnancy smoking in the offspring ADHD.
	The association between pregnancy smoking and offspring ADHD can mainly be ascribed to unmeasured genetic or shared familial environment.
	Clinicians should still pay attention to the higher risk of ADHD in children born of mothers who smoke, where they may detect early sign of the ADHD symptoms and provide early treatment to ensure better outcomes.
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Table 1 Characteristics of the study population
		HKD or medication (6+ months)	Maternal smoking in pregnancy
	N, total	n	Per 1000	n	%
Total	968 665	17 381	17.9	234 178	24.2
Birth year					
  1991-1994	240 660	5 559	23.1	76 231	31.7
  1995-1999	305 540	7 320	24.0	77 324	25.3
  2000-2004	302 178	4 295	14.2	61 169	20.2
  2005-2006	120 287	207	1.7	19 454	16.2
Sex					
  Boys	496 943	13 524	27.2	120 265	24.2
  Girls	471 722	3 857	8.2	113 913	24.1
Maternal age,  years					
  <21	24 583	1 051	42.8	10 791	43.9
  21-25	158 950	4 373	27.5	52 397	33.0
  26-30	376 886	6 507	17.3	84 909	22.5
  31-35	295 159	3 967	13.4	61 085	20.7
  36+	113 087	1 483	13.1	24 996	22.1
Parity					
  1	223 675	4 100	18.3	65 272	29.2
  2	485 186	8 669	17.9	111 111	22.9
  3	201 418	3 582	17.8	44 284	22.0
  4+	58 386	1 030	17.6	13 511	23.1
Preterm birth					
  <37 weeks	44 082	1 189	27.0	13 564	30.8
  37+ weeks	919 220	16 054	17.5	219 109	23.8
  Missing	5 363	138	25.7	1 505	28.1
Birth weight					
  <2500 g	32 600	976	29.9	13 424	41.2
  2500+ g	931 026	16 302	17.5	219 585	23.6




Table 2 Hazard ratio of ADHD, as defined by diagnosis or medication (6+ months), in children of mothers who smoked in pregnancy compared to children of mothers who did not smoke in pregnancy
	N	Crude HR	Adjusted HR	95% CI
Full cohort				
  All	968 665	2.01	2.01	(1.94-2.07)
  Boys	496 943	1.98	1.98	(1.91-2.05)
  Girls	471 722	2.12	2.12	(1.99-2.27)
Sibling analysis				
All siblings				
  All	684 042	0.97	1.07	(0.94-1.22)
  Boys	148 840	1.01	1.08	(0.87-1.32)
  Girls	132 227	1.15	1.19	(0.77-1.84)
  Mixed	402 975	0.93	0.99	(0.86-1.15)
Full siblings				
  All	619 812	0.97	1.11	(0.96-1.28)
  Boys	134 640	1.06	1.16	(0.92-1.47)
  Girls	119 366	1.29	1.33	(0.82-2.15)
  Mixed	365 806	0.89	1.00	(0.85-1.19)
Half-siblings				
  All	75 026	0.98	0.96	(0.75-1.24)
  Boys	15 322	0.92	0.84	(0.52-1.36)
  Girls	13 769	0.75	0.88	(0.30-2.58)
  Mixed	45 935	1.04	1.04	(0.76-1.43)




Table 3 Hazard ratio of ADHD, as defined by diagnosis or medication (6+ months), in children of mothers who smoked in pregnancy according to smoking dose, children of mothers who did not smoke in pregnancy as reference
Smoking dose	Crude HR	Adjusted HR	95% CI
Full cohort			
  Not-smoking	1.00	1.00	




  1-10 cig/day	2.07	1.92	(1.81-2.02)









  1-10 cig/day	1.03	1.07	(0.81-1.40)








  1-10 cig/day	1.08	1.17	(0.86-1.60)








  1-10 cig/day	0.97	0.87	(0.47-1.59)
  10+ cig/day	1.12	1.03	(0.51-2.06)




Table 4 Hazard ratio of low birth weight in children of mothers who smoked in pregnancy, children of mothers who did not smoke in pregnancy as reference
Smoking dose	Crude ORa	Adjusted ORb	95% CI
Full cohort			
  Not-smoking	1.00	1.00	




  1-10 cig/day	2.38	2.31	(2.19-2.42)









  1-10 cig/day	1.77	1.65	(1.30-2.09)








  1-10 cig/day	1.76	1.62	(1.24-2.11)








  1-10 cig/day	1.72	1.54	(0.86-2.78)
  10+ cig/day	1.83	1.88	(0.96-3.68)
Low birth weight is defined as birth weight below 2500 g. OR: odds ratio. CI: confidence interval.
aAdjusted for gestational age.
bAdjusted for gestational age, sex, birth year, parity, and mother's age.
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